Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Adams

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
European Journal of Clinical Nutrition|May 28, 2015
Longitudinal association of measures of adiposity with serum antioxidant concentrations in postmenopausal womenG C Kabat, M Heo, H M Ochs-Balcom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E Lamberts, Maximillian Koch, Johannes S de Jong, et al.
Cancer Research|November 24, 2016
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Johannes S de Jong, Jürgen Glatz, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
European Journal of Clinical Nutrition|May 28, 2015
Longitudinal association of measures of adiposity with serum antioxidant concentrations in postmenopausal womenG C Kabat, M Heo, H M Ochs-Balcom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E Lamberts, Maximillian Koch, Johannes S de Jong, et al.
Cancer Research|November 24, 2016
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Johannes S de Jong, Jürgen Glatz, et al.
Pageof 7